Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2000 9
2001 10
2002 25
2003 28
2004 35
2005 48
2006 65
2007 96
2008 60
2009 79
2010 67
2011 84
2012 90
2013 84
2014 70
2015 77
2016 73
2017 75
2018 69
2019 53
2020 64
2021 66
Text availability
Article attribute
Article type
Publication date

Search Results

1,192 results
Results by year
Filters applied: . Clear all
Page 1
Quetiapine for acute bipolar depression: a systematic review and meta-analysis.
Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Suttajit S, et al. Drug Des Devel Ther. 2014 Jun 25;8:827-38. doi: 10.2147/DDDT.S63779. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25028535 Free PMC article. Review.
BACKGROUND: Precise estimated risks and benefits of quetiapine for acute bipolar depression are needed for clinical practice. ...CONCLUSION: Quetiapine monotherapy is effective for acute bipolar depression and the prevention of mania/hypomania switchin …
BACKGROUND: Precise estimated risks and benefits of quetiapine for acute bipolar depression are needed for clinical practice. …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Yatham LN, et al. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. Bipolar Disord. 2018. PMID: 29536616 Free PMC article.
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine. ...In addition to addressing issues in bipolar I disorder, these guidelines also provide an ove …
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, l …
Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
Ketter TA, Miller S, Dell'Osso B, Wang PW. Ketter TA, et al. J Affect Disord. 2016 Feb;191:256-73. doi: 10.1016/j.jad.2015.11.002. Epub 2015 Nov 25. J Affect Disord. 2016. PMID: 26688495 Review.
Completion of Bipolar CHOICE offers a timely opportunity to review the evidence regarding lithium and quetiapine for bipolar disorder. ...Combination therapy including quetiapine and lithium was generally more effective than either agent alone in acute …
Completion of Bipolar CHOICE offers a timely opportunity to review the evidence regarding lithium and quetiapine for bipola
Quetiapine for insomnia: A review of the literature.
Anderson SL, Vande Griend JP. Anderson SL, et al. Am J Health Syst Pharm. 2014 Mar 1;71(5):394-402. doi: 10.2146/ajhp130221. Am J Health Syst Pharm. 2014. PMID: 24534594 Review.
As such, quetiapine is widely used off-label as a treatment for insomnia. Due to quetiapine's potential adverse effects, guidelines for the treatment of insomnia have recommended the drug's use only in patients with specific comorbid psychiatric disord …
As such, quetiapine is widely used off-label as a treatment for insomnia. Due to quetiapine's potential adverse effects …
Use of quetiapine in children and adolescents.
Masi G, Milone A, Veltri S, Iuliano R, Pfanner C, Pisano S. Masi G, et al. Paediatr Drugs. 2015 Apr;17(2):125-40. doi: 10.1007/s40272-015-0119-3. Paediatr Drugs. 2015. PMID: 25686575 Review.
Most of these studies suggest that quetiapine may be a promising agent with a potential for use in young patients. The aim of this paper is to critically review available literature on quetiapine in the treatment of children and adolescents with a variety of psychia …
Most of these studies suggest that quetiapine may be a promising agent with a potential for use in young patients. The aim of this pa …
Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
Kishi T, Yoshimura R, Sakuma K, Okuya M, Iwata N. Kishi T, et al. Neuropsychopharmacol Rep. 2020 Dec;40(4):417-422. doi: 10.1002/npr2.12137. Epub 2020 Sep 9. Neuropsychopharmacol Rep. 2020. PMID: 32902200 Free PMC article.
AIM: This systematic review and random-effect model, network meta-analysis of the phase 3 trials in Japan assessed the efficacy and safety profile of lurasidone compared with olanzapine and quetiapine extended-release (QUE-XR) for the treatment of bipolar depression …
AIM: This systematic review and random-effect model, network meta-analysis of the phase 3 trials in Japan assessed the efficacy and safety p …
Quetiapine monotherapy for bipolar depression.
Janicak PG, Rado JT. Janicak PG, et al. Expert Opin Pharmacother. 2011 Jul;12(10):1643-51. doi: 10.1517/14656566.2011.585461. Epub 2011 May 24. Expert Opin Pharmacother. 2011. PMID: 21609188 Review.
AREAS COVERED: The article examines the mechanism of action and pharmacokinetics of quetiapine, its evidence base as a treatment for bipolar depression and related issues of safety and tolerability. EXPERT OPINION: In the context of bipolar disorder, queti
AREAS COVERED: The article examines the mechanism of action and pharmacokinetics of quetiapine, its evidence base as a treatment for …
The role of quetiapine in the treatment of bipolar disorder.
Pini S, Abelli M, Cassano GB. Pini S, et al. Expert Opin Pharmacother. 2006 May;7(7):929-40. doi: 10.1517/14656566.7.7.929. Expert Opin Pharmacother. 2006. PMID: 16634715 Review.
Through a review of randomised, controlled trials, this article evaluates the efficacy and tolerability of quetiapine in the acute and maintenance phases of bipolar disorder. ...With regard to the prevention of relapses in bipolar disorder, quetiapine
Through a review of randomised, controlled trials, this article evaluates the efficacy and tolerability of quetiapine in the acute an …
Quetiapine: a review of its use in the management of bipolar depression.
Sanford M, Keating GM. Sanford M, et al. CNS Drugs. 2012 May 1;26(5):435-60. doi: 10.2165/11203840-000000000-00000. CNS Drugs. 2012. PMID: 22519923 Review.
Quetiapine (Seroquel) is an orally administered atypical antipsychotic that is indicated for the treatment of schizophrenia and bipolar disorder, including bipolar depression. An extended-release (XR) formulation of quetiapine is also available. This r
Quetiapine (Seroquel) is an orally administered atypical antipsychotic that is indicated for the treatment of schizophrenia and bi
Safety and efficacy of quetiapine in bipolar depression.
Bogart GT, Chavez B. Bogart GT, et al. Ann Pharmacother. 2009 Nov;43(11):1848-56. doi: 10.1345/aph.1M193. Epub 2009 Oct 6. Ann Pharmacother. 2009. PMID: 19809011 Review.
OBJECTIVE: To review the clinical data investigating the efficacy and safety of quetiapine in bipolar depression. DATA SOURCES: Searches of MEDLINE and PubMed (1977-July 2009) were conducted using the key words quetiapine and bipolar depression. ...DAT …
OBJECTIVE: To review the clinical data investigating the efficacy and safety of quetiapine in bipolar depression. DATA SOURCES …
1,192 results